As ESMO 2025 came to a close last month, pharmaphorum had the pleasure of catching up with Dr Sandeep Reddy, Chief Medical ...

Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection treatments, today ...

At the conference, Acuitas' Chief Scientific Officer, Dr. Ying Tam, showcased the company's Next-Generation LNP advancements, a comprehensive approach that uses multiple technologies and strategies to ...

Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that interim data from Cohort A o ...

The review analyzes red meat's effects on inflammatory biomarkers, revealing significant associations with CRP in specific ...

The study identifies gut microbiome alterations in allergic rhinitis, suggesting a gut-nose axis that could inform new ...

Incyte today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Minjuvi® ...

A new study led by University of Toronto researchers has shown that immune cells in the gut follow an atypical pathway to ...

A new study has discovered a molecular signal that tumors exploit to exhaust the T cells meant to destroy them—and how ...

Research details the importance of maintaining the body's rhythm for optimal health so NBC News medical contributor Dr. John ...

The field of tissue-immune interactions has undergone significant transformation as emerging evidence demonstrates the centrality of local microenvironments ...